drugset / Trial / NCT03166111

Lidocaine In-situ Gel Prior to Intrauterine Device Insertion in Women With no Previous Vaginal Delivery

NCT03166111 ↗

Phase 3 Completed 216 enrolled Assiut University
RandomizedParallel-groupTriple-blindTreatment

Summary

Long-acting reversible contraception methods are highly effective methods for reduction of the unplanned pregnancy rate worldwide. The intrauterine device is a single procedure that provides reliable, effective and long term contraception for many women. However, the insertion procedure can be associated with a troublesome degree of pain that prevent some women from choosing its use. Different interventions have been described to decrease pain perception during intrauterine device insertion with no agreement on an effective one. Pre-insertion oral ibuprofen, diclofenac, nitroprusside, local anesthetics as lidocaine and prostaglandins has been reported with variable degrees of success .

Timeline

Start
2017-09-01
Primary completion
2020-03-31
Completion
2020-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 2 % Other
Subject Lidocaine Other / unclassified 5 ml Other

Indications

No indication recorded.